ArticleFrontiers in medicine2026
Optimizing beta-blocker therapy in cardiovascular care: a national cross-sectional assessment of physicians' and nurses' knowledge, attitudes, and practices in Saudi Arabia.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Beta-blockers are a cornerstone of guideline directed medical therapy for cardiovascular diseases; however, their underutilization remains a global concern. Healthcare professionals' knowledge, attitudes, and practices play a critical role in optimizing beta-blocker prescribing and monitoring. This study aimed to assess the knowledge, attitudes, and practices of physicians and nurses regarding beta-blocker use in cardiovascular patients in Saudi Arabia. Methods: A national cross-sectional study was conducted among physicians and nurses working in government hospitals across Saudi Arabia. Data were collected using a structured self-administered questionnaire assessing demographics, knowledge, attitudes and practices related to beta-blocker use and monitoring. Descriptive statistics, group comparisons, and multivariable linear regression analyses were performed. Results: A total of 553 healthcare professionals participated, including 249 physicians (45.0%) and 304 nurses (55.0%). The median knowledge score was 6.0 (IQR: 5.0-8.0). Nurses demonstrated higher knowledge in titration principles (79.3% vs. 59.8%, Conclusion: Healthcare professionals in Saudi Arabia demonstrated moderate knowledge regarding beta-blocker therapy, with distinct professional differences in knowledge domains and perceived barriers. Fear of adverse effects emerged as a key obstacle to optimal beta-blocker use, particularly among nurses. Targeted educational interventions, unified institutional protocols, and enhanced interprofessional collaboration are needed to improve adherence to guideline-directed beta-blocker therapy and optimize cardiovascular outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.